Roivant Sciences ROIV Balance Sheet Statement
| Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | ||
|---|---|---|---|---|---|---|
| $1.42B+1,411% | $91.94M-7.2% | $102.19M-17.2% | $94.79M-98.3% | $93.95M-48.6% | ||
| $2.87B+32.3% | $3.05B-3.3% | $3.15B-8.1% | $3.26B— | $2.17B— | ||
| —— | $2.61M-15.8% | $2.26M-27.4% | $2.26M-58.3% | $2.36M-23.1% | ||
| $105.32M-6.9% | $129.91M+125% | $125.81M+129% | $112.6M+96.6% | $113.17M+40.4% | ||
| —— | $0— | —— | —— | $9.98M— | ||
| $5.17B+3.3% | $4.66B-13.1% | $4.51B-22.2% | $4.62B-23.1% | $5B-25.7% | ||
| $11.99M-0.6% | $13.45M-0.9% | $25.67M+87.7% | $14.87M-16.7% | $12.06M-21.3% | ||
| $80.42M-9.7% | $83.56M-8.1% | $85.14M+98.1% | $87.08M+92.2% | $89.02M+102% | ||
| $40.92M+24.5% | $34.56M+2.0% | $27.83M-24.6% | $31.09M-5.2% | $32.86M-12.8% | ||
| $407.99M+34.7% | $433.91M+49.6% | $412.32M+32.4% | $283.81M+7.9% | $302.94M+22.3% | ||
| $5.71B+5.0% | $5.23B-9.8% | $5.06B-18.4% | $5.03B-22.5% | $5.44B-24.7% | ||
| $18M-24.0% | $13.29M-43.9% | $15.06M-40.0% | $11.55M-58.4% | $23.69M+68.9% | ||
| $583K-50.1% | $38.11M-3.0% | $26.37M-32.1% | $26.53M-29.9% | $1.17M-91.6% | ||
| —— | $3.05M+0.4% | —— | —— | $1.17M-72.0% | ||
| $11.15M+13.3% | $10.44M+6.1% | $9M-5.4% | $9.4M-0.9% | $9.84M+9.8% | ||
| $45.69M+10,883% | $7.17M+1,144% | $21.26M+293% | $21.26M-9.3% | $416K-95.7% | ||
| —— | $26K— | —— | —— | $0— | ||
| $281.24M+88.2% | $151.96M+7.4% | $133.86M-75.9% | $113.87M-47.1% | $149.41M-44.0% | ||
| $96.29M+6.6% | $98.5M+8.9% | $89.84M+108% | $90.29M+96.9% | $90.33M+101% | ||
| $107.44M+7.3% | —— | —— | —— | $100.17M+75.3% | ||
| $70K+218% | $677K+121% | $170K-42.4% | $228K-86.3% | $22K-99.1% | ||
| $416.28M+66.7% | $251.14M-2.0% | $257.14M-58.9% | $216.7M-64.0% | $249.74M-67.7% | ||
| $0— | $7B0.0% | $7B0.0% | $7B0.0% | $0— | ||
| $5.02B+10.1% | $4.94B+4.7% | $4.77B-0.1% | $4.64B-2.9% | $4.56B-15.5% | ||
| -$501.81M-532% | -$695M-251% | -$429.11M-208% | -$315.59M-147% | $116.06M-79.9% | ||
| $4.36M-53.8% | $20.61M+156% | $19.56M+208% | $17.14M+195% | $9.44M+331% | ||
| $765.04M+53.1% | $704.97M+103% | $443.13M+3.8% | $470.27M+2.2% | $499.59M+4.1% | ||
| $4.53B-3.4% | $4.27B-17.7% | $4.36B-15.3% | $4.35B-20.0% | $4.69B-21.5% | ||
| $5.71B+5.0% | $5.23B-9.8% | $5.06B-18.4% | $5.03B-22.5% | $5.44B-24.7% | ||
| —— | $1.49B-25.6% | $1.25B-38.5% | $1.25B-78.1% | $2.73B-58.4% | ||
| —— | $4.53B-12.0% | $4.39B-18.6% | $4.5B— | $4.89B-24.8% | ||
| $770.24M— | —— | —— | —— | $0— | ||
| $2.87B+32.3% | $3.05B-3.3% | $3.15B-8.1% | $3.26B— | $2.17B— | ||
| $105.32M-6.9% | $129.91M-40.3% | $125.81M+33.5% | $112.6M-65.1% | $113.17M+40.4% | ||
| $40.92M+24.5% | $34.56M+2.0% | $27.83M-24.6% | $31.09M-5.2% | $32.86M-12.8% | ||
| $80.42M-9.7% | $83.56M-8.1% | $85.14M+98.1% | $87.08M+92.2% | $89.02M+102% | ||
| $80.42M-9.7% | $83.56M-8.1% | $85.14M+98.1% | $87.08M+92.2% | $89.02M+102% | ||
| $40.92M+24.5% | $34.56M+2.0% | $27.83M-24.6% | $31.09M-5.2% | $32.86M-12.8% | ||
| $80.42M-9.7% | $83.56M-8.1% | $85.14M+98.1% | $87.08M+92.2% | $89.02M+102% | ||
| $40.92M+24.5% | $34.56M+2.0% | $27.83M-24.6% | $31.09M-5.2% | $32.86M-12.8% | ||
| —— | $38.11M-3.0% | $26.37M-32.1% | $26.53M-29.9% | $53.93M+8.1% | ||
| $205.82M+80.1% | $117.99M+13.1% | $108.32M-2.8% | $88.73M-35.8% | $114.29M-4.3% | ||
| $205.82M+80.1% | $117.99M+13.1% | $108.32M-2.8% | $88.73M-35.8% | $114.29M-4.3% | ||
| —— | $3.05M+0.4% | —— | —— | $1.17M-72.0% | ||
| —— | $38.11M-3.0% | $26.37M-32.1% | $26.53M-29.9% | $53.93M+8.1% | ||
| $583K-50.1% | $10.24M+184% | $1.48M-83.5% | $4.19M-84.8% | $1.17M-91.6% | ||
| —— | $0— | —— | —— | $9.98M— | ||
| —— | $14M— | $14M— | —— | —— | ||
| —— | $10M— | $10.1M— | —— | —— | ||
| —— | $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| —— | 709.7M-1.4% | 689.7M-5.9% | 682.2M-7.7% | 695.9M-13.7% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| —— | 0— | 0— | 0— | 348.5K— | ||
| —— | $0— | —— | —— | $9.98M— | ||
| —— | $55.72M+4.2% | $58.93M+4.7% | $49.8M+7.2% | $45.81M+21.5% | ||
| —— | $1.49B-25.6% | $1.25B-38.5% | $1.25B-78.1% | $2.73B-58.4% | ||
| —— | $00.0% | $00.0% | $00.0% | $00.0% | ||
| —— | $7B0.0% | $7B0.0% | $7B0.0% | $7B0.0% | ||
| —— | $709.69M-1.4% | $689.7M-5.9% | $682.23M-7.7% | $695.94M-13.7% | ||
| —— | $709.69M-1.4% | $689.7M-5.9% | $682.23M-7.7% | $695.94M-13.7% | ||
| —— | $0— | —— | —— | $9.98M— | ||
| $407.99M+34.7% | $433.91M+49.6% | $412.32M+32.4% | $283.81M+7.9% | $302.94M+22.3% | ||
| —— | $0.09— | —— | —— | —— | ||
| $0-100% | $0-100% | $33.27M+26.7% | $12.31M-54.2% | $9.98M-61.2% | ||
| —— | —— | —— | —— | —— | ||
| $765.04M+53.1% | $704.97M+103% | $443.13M+3.8% | $470.27M+2.2% | $499.59M+4.1% | ||
| —— | $1.39B-26.7% | $1.13B-23.1% | $1.14B— | $2.62B-58.5% | ||
| —— | $24.16M+109% | $23.02M+41.1% | $12.39M-52.8% | $14.55M-54.3% | ||
| —— | $26K— | —— | —— | $0— | ||
| —— | $39.1M— | $39.1M— | —— | —— | ||
| —— | $0— | $0— | $0— | $348.53K— | ||
| $38.67M— | —— | —— | —— | $0— | ||
| —— | $300K— | $1M— | —— | —— | ||
| —— | $39.1M— | $39.1M— | —— | —— | ||
| —— | $800K— | $0— | —— | —— | ||
| —— | 8.5%— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Roivant Sciences's total assets?
- Roivant Sciences (ROIV) holds $5.7B in total assets, up 5.0% year over year.
- How much debt does Roivant Sciences have?
- Roivant Sciences carries $107.4M in total debt against $4.5B of shareholders' equity, a debt-to-equity ratio of 0.02.
- How much cash does Roivant Sciences have?
- Roivant Sciences holds $1.4B in cash and equivalents.
- Can Roivant Sciences cover its short-term obligations?
- Its current ratio is 18.37 — current assets exceed current liabilities.
- Where does Roivant Sciences's balance sheet data come from?
- Every line is extracted from Roivant Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
